Amgen Inc (AMGN)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$429.00
Buy
$431.00
$5.90 (+1.41%)
Prices updated at 18 Aug 2026, 13:16 EDT
| Prices minimum 15 mins delay
Prices in USD
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first c ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| $427.39 - $420.72 | |
| $427.39 - $269.77 | |
| 2.54 | |
| 230,076.48m | |
| 26.41 | |
| - | |
| 4,015 | |
| 19.68 | |
| 2,698,841.34 | |
| -0.09 | |
| 538.80m | |
| US0311621009 | |
| 16.10 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.